Correlation Between Neurocrine Biosciences and Rocky Mountain

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Rocky Mountain at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Rocky Mountain into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Rocky Mountain High, you can compare the effects of market volatilities on Neurocrine Biosciences and Rocky Mountain and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Rocky Mountain. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Rocky Mountain.

Diversification Opportunities for Neurocrine Biosciences and Rocky Mountain

-0.48

Correlation Coefficient

Neurocrine Biosciences  Rocky Mountain

Very good diversification

The 3 months correlation between Neurocrine and Rocky is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Rocky Mountain High in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rocky Mountain High and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Rocky Mountain. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rocky Mountain High has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Rocky Mountain go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Rocky Mountain

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 18.52 times less return on investment than Rocky Mountain. But when comparing it to its historical volatility, Neurocrine Biosciences is 24.42 times less risky than Rocky Mountain. It trades about 0.24 of its potential returns per unit of risk. Rocky Mountain High is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  0.62  in Rocky Mountain High on September 25, 2024 and sell it today you would earn a total of  0.08  from holding Rocky Mountain High or generate 12.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Neurocrine Biosciences  vs.  Rocky Mountain High

Neurocrine Biosciences

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Rocky Mountain High

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Rocky Mountain High are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating technical indicators, Rocky Mountain sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neurocrine Biosciences and Rocky Mountain

The main advantage of trading using opposite Neurocrine Biosciences and Rocky Mountain positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Rocky Mountain can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rocky Mountain will offset losses from the drop in Rocky Mountain's long position.

The idea behind Neurocrine Biosciences and Rocky Mountain High pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.